REFILE-Lilly says Taltz superior to Humira in late-stage psoriatic arthritis trial
December 17, 2018 at 06:48 AM EST
Eli Lilly and Co said on Monday its psoriatic arthritis drug, Taltz, was found to be more effective than the world's best-selling prescription medicine, AbbVie Inc's Humira, in a late-stage trial.